mRNA Cancer Vaccine Begins Trials for Non-Small Cell Lung Cancer

An mRNA vaccine has entered human trials as a treatment for lung cancer. Unlike traditional cancer vaccines such as the HPV vaccine, BNT116 is a therapeutic cancer vaccine designed to reduce tumor growth in patients with cancer or prevent its recurrence.

Updated COVID Vaccines Approved by FDA

FDA has approved and granted emergency use authorization for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARSCoV-2.

First Nasal Self-Administered Flu Vaccine Approved by FDA

The first influenza nasal spray vaccine that can be self-administered has been approved by the U.S. Food and Drug Administration (FDA).

Nasal COVID-19 Vaccine Halts Transmission of SARS-CoV-2

A study by researchers at Washington University School of Medicine in St. Louis indicates next-generation vaccines that target a virus’s points of entry — the nose and mouth — may be able to contain the spread of respiratory infections and prevent transmission.

Universal Flu Vaccine May Be Available in Five Years

New research reveals a promising approach to a universal influenza vaccine vaccine that confers lifetime immunity against an evolving virus.

Increasing Vaccine Development Provides Hope, Despite Resistance

It’s alarming that despite vaccines’ proven success, some 40,000 to 50,000 adults die from vaccine-preventable diseases each year. Even diseases that were once-eradicated are making a comeback.

COVID Vaccines: What’s Available Now and What’s in the Works?

Three top vaccine producers are making newer vaccines that not only protect against the newer sublineages of COVID-19, but that also protect against other respiratory viruses.

Viruses, Variants and Vaccines: Staying Ahead of the Spread

Although history has proven the success of vaccines in controlling the spread of diseases, emerging threats are concerning. However, hope is on the horizon with studies of newer vaccines.

Study Shows Vaccination Decision in IEI Patients Must Be Individualized

Inborn errors of immunity (IEI) increase morbidity and mortality risks, particularly from respiratory tract infections. Hence, vaccination becomes pivotal for IEI patients. 

The Protective Value of RSV Vaccines in Older Adults: A Deeper Dive

Now that safe and effective RSV vaccines are finally available, more evidence of their direct health benefits in older Americans will be forthcoming. It is likely as well that FDA will eventually expand the marketing approvals of these vaccines to include adults under age 60 with chronic conditions demonstrated to importantly increase the risk of RSV-associated LRTD and hospitalization.